메뉴 건너뛰기




Volumn 39, Issue 2, 2009, Pages 192-195

Case report: Anti-tumor necrosis factor-alpha therapy provokes latent leishmaniasis in a patient with rheumatoid arthritis

Author keywords

Adalimumab; Anti TNF ; Leishmaniasis; Monoclonal antibody; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; AMPHOTERICIN B LIPID COMPLEX; IMMUNOGLOBULIN G; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; AMPHOTERICIN B; ANTIINFECTIVE AGENT; ANTIPROTOZOAL AGENT; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

EID: 66349113262     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (17)

References (20)
  • 1
    • 0027317582 scopus 로고
    • Leishmaniases of the new world: Current concepts and implications for future research
    • Grimaldi G Jr, Tesh RB. Leishmaniases of the New World: Current concepts and implications for future research. Clin Microbiol Rev 1993;6:230-250. (Pubitemid 23231207)
    • (1993) Clinical Microbiology Reviews , vol.6 , Issue.3 , pp. 230-250
    • Grimaldi Jr., G.1    Tesh, R.B.2
  • 2
    • 0030249846 scopus 로고    scopus 로고
    • Leishmaniasis reservoirs and their significance in control
    • DOI 10.1016/0738-081X(96)00041-7
    • Ashford RW. Leishmania reservoirs and their significance in control. Clin Dermatol 1996;14:523-532. (Pubitemid 26327747)
    • (1996) Clinics in Dermatology , vol.14 , Issue.5 , pp. 523-532
    • Ashford, R.W.1
  • 4
    • 3042555141 scopus 로고    scopus 로고
    • Leishmaniasis: Current situation and new perspectives
    • Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004;27: 305-318.
    • (2004) Comp Immunol Microbiol Infect Dis , vol.27 , pp. 305-318
    • Desjeux, P.1
  • 5
    • 0026592139 scopus 로고
    • Human leishmaniasis: Epidemiology and public health aspects
    • Desjeux P. Human leishmaniasis: epidemiology and public health aspects. World Health Stat Q 1992;45:267-275.
    • (1992) World Health Stat Q , vol.45 , pp. 267-275
    • Desjeux, P.1
  • 6
    • 39549106325 scopus 로고    scopus 로고
    • Leishmaniasis in rheumatoid arthritis
    • Pizzorni C. Leishmaniasis in rheumatoid arthritis. Reumatismo 2007; 59(3):235-239.
    • (2007) Reumatismo , vol.59 , Issue.3 , pp. 235-239
    • Pizzorni, C.1
  • 7
    • 0042027086 scopus 로고    scopus 로고
    • Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-α therapy
    • DOI 10.1093/rheumatology/keg263
    • Kroesen S, Widmer AF, Tyndall A, Hasler P. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-α therapy. Rheumatology 2003;42:617-621. (Pubitemid 37220869)
    • (2003) Rheumatology , vol.42 , Issue.5 , pp. 617-621
    • Kroesen, S.1    Widmer, A.F.2    Tyndall, A.3    Hasler, P.4
  • 8
    • 34247218183 scopus 로고    scopus 로고
    • Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists
    • DOI 10.1002/art.22504
    • Curtis JR, Patkar N, Xie A, Martin C et al. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum 2007;56:1125-1133. (Pubitemid 46608637)
    • (2007) Arthritis and Rheumatism , vol.56 , Issue.4 , pp. 1125-1133
    • Curtis, J.R.1    Patkar, N.2    Xie, A.3    Martin, C.4    Allison, J.J.5    Saag, M.6    Shatin, D.7    Saag, K.G.8
  • 9
    • 33646696885 scopus 로고    scopus 로고
    • Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
    • DOI 10.1001/jama.295.19.2275
    • Bongartz T, Sutton AJ, Sweeting MJ, Matteson EL et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and metanalysis of rare harmful effects in randomized controlled trials. JAMA 2006;295:2275-2285. (Pubitemid 43736578)
    • (2006) Journal of the American Medical Association , vol.295 , Issue.19 , pp. 2275-2285
    • Bongartz, T.1    Sutton, A.J.2    Sweeting, M.J.3    Buchan, I.4    Matteson, E.L.5    Montori, V.6
  • 10
    • 27744603956 scopus 로고    scopus 로고
    • Mycobacterium abscessus infection after use of tumor necrosis factor α inhibitor therapy: Case report and review of infectious complications associated with tumor necrosis factor α inhibitor use
    • DOI 10.1016/j.diagmicrobio.2005.06.006, PII S0732889305001537
    • Mufti AH, Toye BW, McKendry RR, Angel JB. Mycobacterium abscessus infection after use of tumor necrosis factor α inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor α inhibitor use. Diagn Microbiol Infect Dis 2005;53:233-238. (Pubitemid 41607629)
    • (2005) Diagnostic Microbiology and Infectious Disease , vol.53 , Issue.3 , pp. 233-238
    • Mufti, A.H.1    Toye, B.W.2    Mckendry, R.R.J.3    Angel, J.B.4
  • 11
    • 34248644322 scopus 로고    scopus 로고
    • Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: A review of 84 cases
    • DOI 10.1007/s10620-006-9250-x
    • Kaur N, Mahl TC. Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases. Dig Dis Sci 2007;52:1481-1484. (Pubitemid 46776482)
    • (2007) Digestive Diseases and Sciences , vol.52 , Issue.6 , pp. 1481-1484
    • Kaur, N.1    Mahl, T.C.2
  • 12
    • 34447132816 scopus 로고    scopus 로고
    • Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept
    • DOI 10.1007/s10067-006-0356-5
    • Bagalas V, Kioumis I, Argyropoulou P, Patakas D. Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with entanercept. Clin Rheumatol 2007;26:1344-1345. (Pubitemid 47034194)
    • (2007) Clinical Rheumatology , vol.26 , Issue.8 , pp. 1344-1345
    • Bagalas, V.1    Kioumis, I.2    Argyropoulou, P.3    Patakas, D.4
  • 13
    • 40949113730 scopus 로고    scopus 로고
    • Visceral leishmaniasis in a patient with psoriatic arthritis treated with infliximab: Reactivation of a latent infection?
    • Tektonidou MG, Skopouli FN. Visceral leishmaniasis in a patient with psoriatic arthritis treated with infliximab: reactivation of a latent infection? Clin Rheumatol 2008;27:541-542.
    • (2008) Clin Rheumatol , vol.27 , pp. 541-542
    • Tektonidou, M.G.1    Skopouli, F.N.2
  • 15
    • 33750210003 scopus 로고    scopus 로고
    • Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab [4]
    • DOI 10.1093/rheumatology/kel235
    • Bassetti M, Pizzorni C, Gradoni L, Del Bono V, Cutolo M, Viscoli C. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab. Rheumatology 2006;45:1446-1448. (Pubitemid 44605486)
    • (2006) Rheumatology , vol.45 , Issue.11 , pp. 1446-1448
    • Bassetti, M.1    Pizzorni, C.2    Gradoni, L.3    Del Bono, V.4    Cutolo, M.5    Viscoli, C.6
  • 16
  • 17
    • 0036569910 scopus 로고    scopus 로고
    • TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection
    • Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 2002;168:4620-4627. (Pubitemid 34441368)
    • (2002) Journal of Immunology , vol.168 , Issue.9 , pp. 4620-4627
    • Roach, D.R.1    Bean, A.G.D.2    Demangel, C.3    France, M.P.4    Briscoe, H.5    Britton, W.J.6
  • 18
    • 0035932519 scopus 로고    scopus 로고
    • Cytokine pathways and joint inflamation in rheumatoid arthritis
    • DOI 10.1056/NEJM200103223441207
    • Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. NEJM 2001;344:907-916. (Pubitemid 32224400)
    • (2001) New England Journal of Medicine , vol.344 , Issue.12 , pp. 907-916
    • Choy, E.H.S.1    Panayi, G.S.2
  • 20
    • 0032534108 scopus 로고    scopus 로고
    • Host susceptibility factors to cutaneous leishmaniasis
    • Jones DE, Elloso MM, Scott P. Host susceptibility factors to cutaneous leishmaniasis. Front Biosci 1998;3:1171-1180.
    • (1998) Front Biosci , vol.3 , pp. 1171-1180
    • Jones, D.E.1    Elloso, M.M.2    Scott, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.